Many plans may cover FDA-approved medications like Wegovy or Zepbound, though prior authorization or proof of medical necessity may be required
Saxenda specifically licensed for weight management) Dulaglutide (Trulicity, licensed only for diabetes, not weight management) Tirzepatide (Mounjaro), a dual GLP-1 and GIP receptor agonist licensed for type 2 diabetes These medications are administered via subcutaneous injection, typically weekly or daily depending on the specific formulation
They are generally mild to moderate, most intense when starting or increasing the dose, and usually subside with time
Furthermore, T-cell activation in patients with severe IMDD was notably heightened among inpatients with melancholia, and the numbers of pan-T, pan-B, T suppressor/cytotoxic, and CD21 + B cells significantly increased in patients with melancholia [24, 25]
JSTOR 41171130